Unknown PHASE3 INTERVENTIONAL 3-arm NCT02749656

Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis

A Randomized Control Trial of Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) Compared With 0.25% Desoximetasone Cream (Topicorte®) in the Treatment of Scalp Psoriasis

Sponsor: SPS MEDICAL CO.,LTD.

Conditions Scalp Psoriasis

Interventions 0.25% Desoximetasone cream (Topicorte®) 0.25% Desoximetasone cream (Topoxy®) Placebo

Updated 7 times since 2017 Last updated: Apr 28, 2017 Started: Jan 1, 2016 Primary completion: Jan 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Scalp Psoriasis and is currently ongoing. SPS MEDICAL CO.,LTD. leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
May 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jun 2018 — May 2019 [monthly]

Recruiting PHASE3

▶ Show 2 earlier versions

Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jan 2017 — Jun 2017 [monthly]

Not Yet Recruiting PHASE3

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SPS MEDICAL CO.,LTD.
Siriraj Hospital
Siriraj clinical research center

Data source: Siriraj Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand